Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,899,281
-$1,727,639 QoQ
Shares Held
550,746
-21.5% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 164 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $84,469,411 across 15 Drug Manufacturers - General names. GRFS ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
159,049 | $40,393,674 | |
| 2 | MRK |
Merck & Co., Inc.
|
53,638 | $6,892,483 | |
| 3 | OGN |
Organon & Co.
|
497,996 | $6,742,865 | |
| 4 | BIIB |
Biogen Inc.
|
30,914 | $6,679,278 | |
| 5 | LLY |
ELI LILLY & Co
|
3,365 | $4,036,082 | |
| 6 | GRFS |
Grifols SA
This page
|
550,746 | $3,899,281 | |
| 7 | ABBV |
AbbVie Inc.
|
14,719 | $3,703,889 | |
| 8 | SNY |
Sanofi
|
65,000 | $2,772,900 |
All Filings in GRFS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,899,281 | 550,746 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,626,920 | 701,611 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,770,026 | 724,067 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,946,283 | 697,418 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,560,314 | 615,079 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,213,378 | 170,658 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $896,549 | 120,504 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,635,903 | 296,836 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||